Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Notthatbright on Apr 06, 2021 12:27pm

STERN...SUCKS

...what a joke!
Comment by bringon10bagger on Apr 06, 2021 3:39pm
With positive results for Otena to date, I have often wondered what BP actual opinion is of what ATE has done. Do they not see value in what ATE is doing and have accomplished? Does ATE mgmt want a deal at this time or are they holding out for bigger payout. Feeling mgmt is holding their cards kinda close, is it due to current negoitiations? So much to understand, retail is tired of hearing the ...more  
Comment by Notthatbright on Apr 06, 2021 3:43pm
OTCQX  is the problem....need an uplist.
Comment by Doccole on Apr 06, 2021 4:16pm
The Sterns contract should be up at this time.  I believe the contract said that they could go month to month... the original plan was underground grass roots promotion in the US and then a uplist.  That didn't transpire. I'm waiting for CEO Dan to say....We are headed for exciting times, our lead drug is ready for partnering and we are gearing up for a NASDQ uplist in 2022. & ...more  
Comment by Harper75 on Apr 06, 2021 4:21pm
It's so funny cause it's true...or likely.  Well said Doccole. 
Comment by StockingUp21 on Apr 06, 2021 8:58pm
Stern are listed on news released March 29. How much do they make and what do they do/done? There is a phone number there 
Comment by Layth1990 on Apr 06, 2021 9:40pm
Ofcourse it sucks, 17,500 /month since Augest. That is more than 150k. Wake up antibe, terminate this contract and hire someone better. We are not a charity, it is our ( investors ) money. 
Comment by WalkOverTheStrt on Apr 06, 2021 11:12pm
make your voices heard - email IR. I did on why us volume is anemic / is mgmt satisfied with it... INVESTOR CONTACT Christina Cameron VP Investor Relations +1 416-577-1443 christina@antibethera.com
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities